CureVac N.V. (BIT:1CVAC)

Italy flag Italy · Delayed Price · Currency is EUR
4.542
-0.088 (-1.90%)
At close: Sep 22, 2025
61.29%
Market Cap 1.03B
Revenue (ttm) 510.51M
Net Income (ttm) 193.64M
Shares Out n/a
EPS (ttm) 0.86
PE Ratio 5.34
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,358
Average Volume 823
Open 4.780
Previous Close 4.630
Day's Range 4.516 - 4.780
52-Week Range 2.146 - 4.936
Beta n/a
RSI 44.28
Earnings Date Nov 12, 2025

About CureVac

CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). The company’s portfolio includes clinical and preclinical candidates for various disease indications in prophylactic vaccines, oncology, and molecular therapy. It also delivers optimized mRNAs to stimulate the production of therapeutic proteins utilizing its technology and instructs human cells to produce or secrete specific proteins in the nucleus, cytoplasm, cellular organelles, and cell membrane. In ad... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Employees 983
Stock Exchange Borsa Italiana
Ticker Symbol 1CVAC
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.